Health Condition 1: C480- Malignant neoplasm of retroperitoneum
Conditions
Interventions
Intervention1: NIL: NIL
Intervention2: Nil: Nil
Control Intervention1: NIL: NIL
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Consecutive adult patients (18 years and above) of both sexes with patients with Recurrent RP sarcomas. 2. Date of surgery between January 2011 to December 2024
Exclusion criteria
Exclusion criteria: 1. Non-retroperitoneal, intra-abdominal sarcomas 2. Chemo-sensitive and radiosensitive histologies like Ewing?s sarcoma which have management protocols different from other RP sarcomas.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival in patients with recurrent retroperitoneal sarcomas and retroperitoneal sarcoma with multiple recurrencesTimepoint: after surgery for first 2 years after every 3 months, then every 6 month for next 3 yrs and then every year | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of factors associated with multiple recurrencesTimepoint: after surgery for first 2 years after every 3 months, then every 6 month for next 3 yrs & then every year;Difference in OS between Rec RPS after adequate surgery Vs Rec RPS after inadequate surgeryTimepoint: after surgery for first 2 years after every 3 months, then every 6 month for next 3 yrs & then every year | — |
Countries
India
Contacts
Public ContactDr Shraddha Patkar
Tata Memorial Hospital
Outcome results
None listed